UNSPSC 51282100: Beta-lactams

This classification denotes antibiotics which consist of four-membered cyclic amides and lactams, often based on a bicyclo-thiazolidine.

UNSPSC 51282100 Beta-lactams is a Class code that covers pharmaceutical products in the beta-lactam antibiotic family, though recent state and local procurement activity under this code shows limited direct solicitation. The two posted opportunities in the dataset reflect broader pharmaceutical purchasing patterns rather than beta-lactam-specific procurements: the Illinois Department of Public Health awarded a $2,999,999.11 piggyback pharmaceutical warehouse contract through the MMCAP Infuse consortium to Chartwell Rx LLC for Doxycycline Hyclate 100mg tablets and Ciprofloxacin Hydrochloride 500mg tablets (neither of which are beta-lactams), while Seminole County, Florida issued an IFB for Naloxone and Safe Drug Deactivation Systems (opioid antagonists and harm-reduction equipment, unrelated to beta-lactams). State and local health departments and counties represent the primary issuing bodies for pharmaceutical procurement under related codes, typically purchasing through cooperative vehicles such as MMCAP Infuse or direct competitive bidding with multi-year terms and renewal options.

The geographic spread of recent activity captures Illinois and Florida, with activity driven by state health departments and county health offices. The Illinois Department of Public Health contract, awarded August 28, 2026 via IFB with response due September 11, 2026, demonstrates cooperative-purchasing patterns in which state agencies piggyback on consortium contracts to manage pharmaceutical inventories across multiple renewal periods. Seminole County's June 30, 2026 IFB (response due July 26, 2026) shows county-level procurement for community health initiatives with quarterly delivery requirements and two-year initial terms with one-year renewal options. Neither opportunity directly targets beta-lactam products, suggesting the code may see limited standalone solicitation activity at the state and local level or that procurement officers are tagging broader pharmaceutical purchases without precise UNSPSC specificity.